Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 32; no. 6; pp. 1412 - 1415
Main Authors Hołowiecki, J., Wojciechowska, M., Giebel, S., Krawczyk-Kuliś, M., Wojnar, J., Kachel, Ł., Kata, D., Markiewicz, M.
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.09.2000
Elsevier Science
Subjects
Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Bone marrow, stem cells transplantation. Graft versus host reaction
Cyclophosphamide - therapeutic use
Drug Therapy, Combination
Epirubicin - therapeutic use
Etoposide - therapeutic use
Female
Granulocyte Colony-Stimulating Factor - adverse effects
Granulocyte Colony-Stimulating Factor - therapeutic use
Hematopoiesis
Hematopoietic Stem Cell Mobilization - methods
Hematopoietic Stem Cell Transplantation
Hodgkin Disease - drug therapy
Hodgkin Disease - radiotherapy
Hodgkin Disease - therapy
Humans
Ifosfamide - therapeutic use
Lymphoma, Non-Hodgkin - drug therapy
Lymphoma, Non-Hodgkin - radiotherapy
Lymphoma, Non-Hodgkin - therapy
Male
Medical sciences
Middle Aged
Multiple Myeloma - drug therapy
Multiple Myeloma - radiotherapy
Multiple Myeloma - therapy
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Stem cell
Hematopoietic cell
Blood
Granulocyte colony stimulating factor
Isomerases
Epirubicin
Antimitotic
Human
DNA topoisomerase (ATP-hydrolysing)
Drug combination
Enzyme
Ifosfamide
Treatment efficiency
Cytokine
Etoposide
Enzyme inhibitor
Podophyllotoxine derivatives
Mobilization
Alkylating agent
Antibiotic
Blood cell
Chemotherapy
Oxazaphosphinane derivatives
Nitrogen mustard
Anthracyclins
Online AccessGet full text

Cover

More Information
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(00)01276-8